Three-drug combination therapy effective in patients with high-risk CLL, trial shows
NEW ORLEANS – A three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remissions in a broad group of ...
Tag: Threedrug
Three-drug combination slows progression of advanced kidney cancer
Patients treated with the three-drug combination had a 27% lower risk of progression or death compared to those on the ...
Improved progression-free survival in multiple myeloma patients following three-drug therapy with autologous stem cell transplant
BOSTON – Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of ...
Three-drug combination prolongs survival in men with metastatic, hormone-sensitive prostate cancer
BOSTON – Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation ...
-
New study shows snacking on mixed tree nuts may impact cardiovascular risk factors and increase serotonin
-
Ignoring Native American data perpetuates misleading white ‘deaths of despair’ narrative, study finds
-
Mount Sinai researchers awarded $12 million NIH grant to create a center to unravel novel causes of food allergy and atopic dermatitis
-
Hydrogen peroxide from tea and coffee residue: New pathway to sustainability
-
Volcano-like rupture could have caused magnetar slowdown
-
The next generation of global health innovators: Michelson Prize winners announced